| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |